Bank Of Montreal Invitae Corp Transaction History

Bank Of Montreal

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$0.42 - $0.72 $437 - $749	1,041 Added 0.47%	221,922 $139,000
Q3 2023 Nov 01, 2023	BUY	$0.6 - $1.53 $277 - $708	463 Added 0.21%	220,881 $132,000
Q2 2023 Aug 02, 2023	BUY	$1.05 - $1.63 $231,438 - $359,281	220,418 New	220,418 $249,000
Q1 2023 Jun 13, 2024	BUY	$1.2 - $2.73 $210,434 - $478,738	175,362 New	175,362 $236,000
Q3 2022 Nov 10, 2022	SELL	$1.9 - $8.63 $387,220 - $1.76 Million	-203,800 Reduced 40.58%	298,463 $758,000

Q2 2022 Aug 11, 2022	SELL	$2.13 - $9.01 $6,072 - $25,687	-2,851 Reduced 0.56%	502,263 $1.46 Million
Q1 2022 May 12, 2022	BUY	$6.28 - $15.59 $27,186 - $67,489	4,329 Added 0.86%	505,114 $4.25 Million
Q4 2021 Feb 11, 2022	BUY	$14.7 - $28.67 $333,572 - $650,579	22,692 Added 4.75%	500,785 $7.84 Million
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $1.16 Million - $1.6 Million	47,532 Added 11.04%	478,093 $13.7 Million
Q2 2021 Aug 12, 2021	BUY	$26.09 - $40.4 $11.2 Million - $17.4 Million	430,561 New	430,561 $14.8 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.